JASON Views Challenges of Electronic Health Data
The ongoing transition to electronic storage of individual health information was examined in a newly released study from the JASON scientific advisory panel.
“The two overarching goals of moving to the electronic exchange of health information are improved health care and lower health care costs. Whether either, or both, of these goals can be achieved remains to be seen, and the challenges are immense,” the JASON study says.
See A Robust Health Data Infrastructure, prepared for the Department of Health and Human Services, November 2013 (approved for release April 2014).
The JASON study addresses the tension between personal health information, which is “sensitive and therefore must be carefully safeguarded,” and aggregated population health data, which are “a highly valuable, and largely untapped, resource for basic and clinical research.”
“It is in the public interest to make such [aggregated population] information available for scientific, medical, and economic purposes.” Reconciling these competing imperatives of privacy and information sharing is one of the challenges to be overcome.
The JASONs, who normally deal with defense science and technology, strain to affirm a relationship between health and national security. (“From a national security perspective it is important to have an accurate assessment of the current health and potential health vulnerabilities of the population.”)
Interestingly, they suggest that because the United States is less ethnically homogenous than many other countries, it “has a special advantage” in conducting certain types of medical research.
The U.S. “is a genetic melting pot that can be a crucible for discoveries related to personalized medicine and the genetic basis of disease,” the JASONs said.
From California to New Jersey, wildfires are taking a toll—costing the United States up to $424 billion annually and displacing tens of thousands of people. Congress needs solutions.
To secure the U.S. bio-infrastructure, maintain global leadership in biotechnology, and safeguard American citizens from emerging threats to their privacy, the federal government must modernize its approach to human genetic and biological data.
To ensure an energy transition that brings broad based economic development, participation, and direct benefits to communities, we need federal policy that helps shape markets. Unfortunately, there is a large gap in understanding of how to leverage federal policy making to support access to capital and credit.
From use to testing to deployment, the scaffolding for responsible integration of AI into high-risk use cases is just not there.